New diabetes clinical trial: A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Published on: 2026-07-15T04:00:00Z Conditions : Diabetic Retinopathy; Macular Edema Interventions : Drug: MK-8748; Drug: Aflibercept Sponsors : Merck Sharp & Dohme LLC Not yet recruiting https://ift.tt/DPEbiCI